Literature DB >> 16497703

Hepatic oval cell response to the choline-deficient, ethionine supplemented model of murine liver injury is attenuated by the administration of a cyclo-oxygenase 2 inhibitor.

Richard A Davies1, Belinda Knight, Yan Wu Tian, George C T Yeoh, John K Olynyk.   

Abstract

Oval cell proliferation precedes neoplasia in many rodent models of hepatocellular carcinoma and prevention of this proliferative response can reduce the risk of subsequent carcinoma. This study aimed to determine whether a selective cyclo-oxygenase-2 (COX-2) inhibitor, SC-236, affects (i) the oval cell response to liver injury in a mouse model of hepatocarcinogenesis and (ii) an oval cell line. Four-week-old mice were fed either normal chow or a choline deficient, ethionine supplemented (CDE) diet in the presence or absence of SC-236. Liver histology and oval cell numbers were determined after 2, 4, 12 and 52 weeks of treatment. Oval cells were scored using morphological criteria and positive immuno-staining for the M(2)-isozyme of pyruvate kinase (M2PK) or A6. An immortalized oval cell line (PIL-2) was used to study the in vitro effects of SC-236 on oval cell proliferation, apoptosis and Akt phosphorylation. The percentage of M2PK-positive oval cells and COX-2-positive cells was reduced by 80% and 45%, respectively, in CDE-fed mice receiving SC-236 compared with CDE-fed animals not receiving SC-236. Some M2PK-positive oval cells were also COX-2 positive. The percentage of A6-positive cells was not affected by SC-236 administration to CDE-fed mice. Administration of SC-236 increased apoptosis as evidenced by a 73% increase in the number of TUNEL-positive cells at 2 weeks in CDE-fed mice. Primary oval cells and PIL-2 cells expressed COX-2. In vitro treatment of PIL-2 cells with SC-236 resulted in a dose-dependent preferential death of A6-negative cells. Administration of 25 and 50 microM Prostaglandin E(2) partially attenuated SC-236 induced cell death by 25%. In vitro oval cell death was associated with apoptosis and a 70% reduction in Akt phosphorylation. These results suggest that the SC-236 induced reduction of M2PK-positive oval cell numbers may be due to COX-2 dependent inhibition of Akt phosphorylation and induction of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16497703     DOI: 10.1093/carcin/bgi365

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  12 in total

1.  COP9 signalosome subunit 8 is required for postnatal hepatocyte survival and effective proliferation.

Authors:  D Lei; F Li; H Su; Z Tian; B Ye; N Wei; X Wang
Journal:  Cell Death Differ       Date:  2010-08-06       Impact factor: 15.828

2.  Oral N-acetylcysteine rescues lethality of hepatocyte-specific Gclc-knockout mice, providing a model for hepatic cirrhosis.

Authors:  Ying Chen; Elisabet Johansson; Yi Yang; Marian L Miller; Dongxiao Shen; David J Orlicky; Howard G Shertzer; Vasilis Vasiliou; Daniel W Nebert; Timothy P Dalton
Journal:  J Hepatol       Date:  2010-08-11       Impact factor: 25.083

3.  Contributions of new hepatocyte lineages to liver growth, maintenance, and regeneration in mice.

Authors:  Sonya V Iverson; Kristin M Comstock; Jean A Kundert; Edward E Schmidt
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

4.  PPARα-Deficient ob/ob Obese Mice Become More Obese and Manifest Severe Hepatic Steatosis Due to Decreased Fatty Acid Oxidation.

Authors:  Qian Gao; Yuzhi Jia; Gongshe Yang; Xiaohong Zhang; Prajwal C Boddu; Bryon Petersen; Saiprasad Narsingam; Yi-Jun Zhu; Bayar Thimmapaya; Yashpal S Kanwar; Janardan K Reddy
Journal:  Am J Pathol       Date:  2015-03-12       Impact factor: 4.307

Review 5.  The origin, biology, and therapeutic potential of facultative adult hepatic progenitor cells.

Authors:  Soona Shin; Klaus H Kaestner
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

Review 6.  Activation of stem cells in hepatic diseases.

Authors:  T G Bird; S Lorenzini; S J Forbes
Journal:  Cell Tissue Res       Date:  2007-11-29       Impact factor: 5.249

7.  Chlorella vulgaris triggers apoptosis in hepatocarcinogenesis-induced rats.

Authors:  Emey Suhana Mohd Azamai; Suhaniza Sulaiman; Shafina Hanim Mohd Habib; Mee Lee Looi; Srijit Das; Nor Aini Abdul Hamid; Wan Zurinah Wan Ngah; Yasmin Anum Mohd Yusof
Journal:  J Zhejiang Univ Sci B       Date:  2009-01       Impact factor: 3.066

8.  Proliferation of Hepatic Oval Cells via Cyclooxygenase-2 and Extracellular Matrix Protein Signaling during Liver Regeneration Following 2-AAF/Partial Hepatectomy in Rats.

Authors:  Si Hyun Bae; Seh Hoon Oh; Seung Kew Yoon; Joung Ah Park; Gi Dae Kim; Wonhee Hur; Jong Young Choi; Il Hoan Oh; Kun Ho Yoon
Journal:  Gut Liver       Date:  2011-08-18       Impact factor: 4.519

9.  Maraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse model.

Authors:  Laura Ochoa-Callejero; Laura Pérez-Martínez; Susana Rubio-Mediavilla; José A Oteo; Alfredo Martínez; José R Blanco
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

10.  LPS-TLR4 Pathway Mediates Ductular Cell Expansion in Alcoholic Hepatitis.

Authors:  Gemma Odena; Jiegen Chen; Juan Jose Lozano; Jose Altamirano; Daniel Rodrigo-Torres; Silvia Affo; Oriol Morales-Ibanez; Hiroshi Matsushita; Jian Zou; Raluca Dumitru; Juan Caballeria; Pere Gines; Vicente Arroyo; Min You; Pierre-Emmanuel Rautou; Dominique Valla; Fulton Crews; Ekihiro Seki; Pau Sancho-Bru; Ramon Bataller
Journal:  Sci Rep       Date:  2016-10-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.